Krishna Institute of Medical Sciences Ltd Q1 FY2025-2026 Results: Summary
Revenue | ₹878.70Cr |
Net Profits | ₹78.60Cr |
Net Profit Margins | 8.95% |
Krishna Institute of Medical Sciences Ltd’s revenue jumped 26.8% since last year same period to ₹878.70Cr in the Q1 2025-2026. On a quarterly growth basis, Krishna Institute of Medical Sciences Ltd has generated 8.19% jump in its revenue since last 3-months.
Krishna Institute of Medical Sciences Ltd’s net profit fell -9.24% since last year same period to ₹78.60Cr in the Q1 2025-2026. On a quarterly growth basis, Krishna Institute of Medical Sciences Ltd has generated -22.79% fall in its net profits since last 3-months.
Krishna Institute of Medical Sciences Ltd’s net profit margin fell -28.42% since last year same period to 8.95% in the Q1 2025-2026. On a quarterly growth basis, Krishna Institute of Medical Sciences Ltd has generated -28.63% fall in its net profit margins since last 3-months.
FAQs
What was the revenue for Krishna Institute of Medical Sciences Ltd in Q1 results 2025?
The revenue for Krishna Institute of Medical Sciences Ltd in the Q1 results 2025 was ₹878.70Cr.
What was the net profit for Krishna Institute of Medical Sciences Ltd in Q1 results 2025?
The net profit for Krishna Institute of Medical Sciences Ltd in the Q1 results 2025 was ₹78.60Cr.
What was the net profit margin for Krishna Institute of Medical Sciences Ltd in Q1 results 2025?
The net profit margin for Krishna Institute of Medical Sciences Ltd in the Q1 results 2025 was 8.95%.
What was the revenue for Krishna Institute of Medical Sciences Ltd in Q1 results 2024?
The revenue for Krishna Institute of Medical Sciences Ltd in the Q1 results 2024 was ₹693.00Cr.
What was the net profit for Krishna Institute of Medical Sciences Ltd in Q1 results 2024?
The net profit for Krishna Institute of Medical Sciences Ltd in the Q1 results 2024 was ₹86.60Cr.
What was the net profit margin for Krishna Institute of Medical Sciences Ltd in Q1 results 2024?
The net profit margin for Krishna Institute of Medical Sciences Ltd in the Q1 results 2024 was 12.50%.
